Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Base estimates and working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Transdermal drug delivery systems industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Transdermal Drug Delivery Systems Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of chronic diseases
3.3.1.2 Increasing adoption of transdermal patches
3.3.1.3 Growing demand for non-invasive drug delivery system
3.3.2 Industry pitfalls & challenges
3.3.2.1 Limited number of approved medications
3.3.2.2 High cost involved in development of drug delivery systems
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By application
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.7 Advancement in transdermal drug delivery systems
3.8 Transdermal forms containing the specified active substance, %
3.9 Pricing analysis, by type, 2022
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Company positioning matrix
4.4 Competitive analysis of major market players
4.5 Strategic outlook matrix
4.6 Strategy dashboard, 2021
Chapter 5 Transdermal Drug Delivery Systems Market, By Type
5.1 Key type trends
5.2 Transdermal patches
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Drug-in-adhesive patches
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Matrix patches
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4 Reservoir membrane patches
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.5 Microneedle patches
5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Transdermal semisolids
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Gels
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Ointments
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4 Sprays
5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Transdermal Drug Delivery Systems Market, By Application
6.1 Key application trends
6.2 Pain management
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Hormonal application
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Central nervous system disorders
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Cardiovascular diseases
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Others
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Transdermal Drug Delivery Systems Market, By End-use
7.1 Key end-use trends
7.2 Hospitals
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Clinics
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Homecare settings
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Others
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Transdermal Drug Delivery Systems Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Poland
8.3.7 Switzerland
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Thailand
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Peru
8.5.5 Colombia
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
Chapter 9 Company Profiles
9.1 Novartis
9.2 Mylan
9.3 Amneal Pharmaceuticals, Inc
9.4 Zydus Pharmaceuticals, Inc
9.5 UCB
9.6 Hisamitsu Pharmaceutical Co.,Inc
9.7 Corium, Inc.
9.8 Micropoint Technologies.
9.9 Sparsha Pharma International Pvt. Ltd.
9.10 Luye pharma
